Skip to Main Content
Colorectal Cancer Screening
- Sigmoidoscopy versus fecal occult blood tests for colorectal cancer screening
- Computed virtual chromoendoscopy versus conventional colonoscopy
Gall bladder disease
- Comparing ursodeoxycholic acid alone to ursodeoxycholic acid with chenodeoxycholic acid for treating gallstones
Gastric Ulcers
- Omeprazole versus lansoprazole in treating gastric ulcer complications
- Comparing esompeprazole versus pantoprazole for treating gastric ulcers
- Omeprazole versus ranitidine in the treating of gastric ulcers
- Omeprazole versus rabeprazole for the treating peptic ulcers
- Vonoprazan and rebamipide versus esomeprazole and rebamipide for treating Gastric Ulcer Healing
Gastro-Esophageal Reflux Disease
- Omeprazole versus rabeprazole for treating Gastro-Esophageal Reflux Disease
- Comparing pantoprazole versus ranitidine for treating Gastro-Esophageal Reflux Disease
- Esomeprazole vs. lansoprazole for treating Gastro-Esophageal Reflux Disease
- Laparoscopic Antireflux Surgery vs Esomeprazole: Treating Patients with Chronic GERD
- Esomeprazole and Vonoprazan for treating GERD
- Comparing Histamine-2 receptor antagonists versus proton pump inhibitors for treating GERD
Misc. GI topics
- Famotidine vs. lansoprazole for treating gastrointestinal conditions
- Pantoprazole vs. nizatidine for treating erosive oesophagitis
- Comparing rivaroxaban to apixaban for risk of gastrointestinal bleeding in patients being cotreated with a proton pump inhibitor
- Stem cell therapies: a current therapeutic approach for inflammation-associated sigmoid colon diseases
- Glutathione for treating Nonalcoholic Fatty Liver Disease
- Cognitive Behavioral Therapy and Antidepressant Drugs: Improving Quality of Life in Patients with Irritable Bowel Syndrome
- Comparing laparoscopic to open appendectomy
- Helicobacter pylori test-and-treat versus prompt endoscopy for treating dyspepsia
- Comparing treatments of primary Intestinal lymphangiectasia
- Treating inflammatory bowel disease with a low FODMAP diet
- Comparing Dupilumab to placebo for the treatment of eosinophilic esophagitis
- Infliximab compared to Adalimumab for preventing post-operative recurrent Crohn’s disease
